Pediatric Health: Orphazyme Develops Promising New Treatment for Rare, Incurable Neurological Diseases in Children

Researchers from Orphazyme ApS, a Danish biopharmaceutical company, have developed a promising new treatment for a rare genetic metabolic disorder characterized by severe systemic and neurological problems.